A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate the Efficacy, Safety, and Tolerability of IXMYELOCEL-T In Subjects With Critical Limb Ischemia And No Options For Revascularization
|Effective start/end date
|3/1/12 → 2/28/14
- AASTROM BIOSCIENCES, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.